Alvotech Warrant (ALVOW) is a publicly traded the market company. As of May 21, 2026, ALVOW trades at $1.67 with a market cap of $0 and a P/E ratio of 0.00. ALVOW moved +37.22% today. Year to date, ALVOW is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces ALVOW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Alvotech Reports 260% Q1 Revenue Surge, Raises SEK30M via 441,600 SDR Listing on Nasdaq Stockholm: Alvotech says a 10% U.S. tariff on its Iceland-made biosimilars would raise customer costs by under 1% of its 2025 product revenues. Alvotech posted a 260% revenue surge in Q1 2025 and plans to list 441,600 SDRs on Nasdaq Stockholm at up to SEK90, raising SEK30m from May 19.
| Metric | Value |
|---|---|
| Price | $1.67 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
ALVOW analyst coverage data. Average price target: $0.00.